CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a user-friendly point-of-care sensor for measuring specific purines in blood, which could enhance the diagnosis of epilepsy. By exploring purinergic signaling and its role in seizures, the project seeks to identify new biomarkers and therapeutic targets for this chronic brain disease.
Epilepsy is the most common chronic brain disease, affecting ~70 million people worldwide.
Accurately diagnosing epilepsy remains a major clinical challenge due to the lack of non-invasive molecular diagnostic tools.
Purinergic signalling via extracellularly released adenosine triphosphate (ATP) and its downstream purine derivatives is increasingly recognised to contribute to increased hyperexcitability states in the brain, and thus seizures.
Hence, these can be potentially identified as novel p…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Ireland, Dublin
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
United Kingdom, COVENTRY
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
UNIVERSITAETSKLINIKUM FRANKFURT
Germany, Frankfurt Am Main
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
South Korea, SEOUL
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
